Acta Endoscopica

, Volume 40, Issue 5, pp 347–353

Les immunosuppresseurs en pratique dans les MICI

Vidéo-Digest / Video-Digest
  • 43 Downloads

The use of immunosuppressants in the treatment of inflammatory Bowel disease

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. SONIC study group. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 2010;362:1383–95.CrossRefPubMedGoogle Scholar
  3. 3.
    Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory Bowel disease. Gastroenterology. 2008;134:929–36.CrossRefPubMedGoogle Scholar
  4. 4.
    Louis E et al. Infliximab discontinuation in Crohn’s disease: a prospective study. Gastroenterology 2009;136:A961.Google Scholar

Copyright information

© Springer Paris 2010

Authors and Affiliations

  1. 1.Clinique des CèdresCornebarrrieuFrance
  2. 2.CHU RangueilToulouseFrance

Personalised recommendations